	La Marge Brute Sur Les Ventes		Date
Acadia Pharmaceuticals	USD 256.99M	13.15M	2025-09
Adma Biologics	USD 75.63M	8.4M	2025-09
ALKERMES	USD 265.83M	8.06M	2025-09
AstraZeneca	USD 12.39B	5M	2025-12
BioCryst Pharmaceuticals	USD -88.88M	202.74M	2024-12
Bristol-Myers Squibb	USD 8.79B	110M	2025-09
Cipla	INR 41.64B	6.31B	2025-12
Clal Biotechnology	ILS -857K	1.42M	2022-06
Compugen	USD 241K	649K	2025-09
CSL	USD 1.75B	2.53B	2025-06
Dynavax Technologies	USD 78.57M	24.17M	2025-06
Eli Lilly	USD 14.59B	1.48B	2025-09
Esperion Therapeutics	USD -29.52M	32.4M	2024-09
GlaxoSmithKline	GBP 6.18B	106M	2025-12
Grifols	EUR 766.49M	39.74M	2024-12
Halozyme Therapeutics	USD 281.77M	2.41M	2025-09
Ionis Pharmaceuticals	USD 155M	293M	2025-09
J&J	USD 16.6B	118M	2025-12
Merck	USD 13.42B	431M	2025-09
Minerva Neurosciences	-4.27M	26.79M	2024-12
Neurocrine Biosciences	USD 780.9M	104.7M	2025-09
Novartis	USD 10.82B	695M	2025-09
Novavax	USD 23.89M	239.21M	2024-09
Pfizer	USD 3.54B	7.61B	2025-09
Roche Holding	CHF 22.09B	10.04B	2025-12
Sanofi	EUR 8.45B	1.31B	2025-12
Takeda	JPY 790.55B	262.97B	2025-12
Vanda Pharmaceuticals	USD 50.6M	5.5M	2024-12

Minerva Neurosciences La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.